At most, we observed a slight astrocyte response using immunostaining with antibody against glia fibrillary acidic protein (data not shown). These data indicate that clearance of amyloid-β after ...

Misfolded proteins not only lose their normal physiological functions, but can also acquire new properties that drive pathological processes leading to disease. Amyloid plaques comprising tangled ...

"Aβ42 is a protein that defends our brain from ... Dwivedi, A., & Imbimbo, B. P. (2024). Increases in amyloid-β42 slow cognitive and clinical decline in Alzheimer's disease trials.

A new study that provides a multipronged approach to treatment of several neurodegenerative diseases, offers hope for Alzheimer’s Disease, Dementia, and related diseases.Amyloid proteins and peptides ...

Amyloidosis develops from a bone marrow disorder. It occurs when an abnormal protein, called amyloid, builds up and forms deposits in the body. Amyloidosis is closely linked to MM. Amyloid light ...

BIOA B) today announced that it has entered into a global exclusive license agreement with Bristol Myers Squibb (NYSE: BMY) for BioArctic's PyroGlutamate-amyloid-beta (PyroGlu-Aβ) antibody ...